Treffer: RELICT-NI: Replica Detection in Synthetic Neuroimaging-A Study on Noncontrast CT and Time-of-Flight MRA.
Acad Radiol. 2004 Feb;11(2):178-89. (PMID: 14974593)
Phys Med Biol. 2023 May 05;68(10):. (PMID: 37015231)
Med Image Anal. 2024 Apr;93:103100. (PMID: 38340545)
Nat Methods. 2025 Jan;22(1):166-176. (PMID: 39558098)
BMJ. 2025 Feb 5;388:e081554. (PMID: 39909534)
Nat Biomed Eng. 2025 Aug 11;:. (PMID: 40790276)
Neuroimage. 2006 Jul 1;31(3):1116-28. (PMID: 16545965)
Med Image Anal. 2023 Aug;88:102846. (PMID: 37295311)
Sci Rep. 2024 Jul 16;14(1):16465. (PMID: 39013990)
Knowl Based Syst. 2023 Oct 25;278:. (PMID: 37780058)
Nat Commun. 2024 Jan 22;15(1):654. (PMID: 38253604)
NPJ Digit Med. 2024 Aug 3;7(1):203. (PMID: 39097662)
Neuroimage. 2024 Dec 15;304:120936. (PMID: 39586344)
Sci Rep. 2023 May 5;13(1):7303. (PMID: 37147413)
Neuroimage. 2022 Oct 15;260:119474. (PMID: 35842095)
Nat Methods. 2021 Feb;18(2):203-211. (PMID: 33288961)
Comput Biol Med. 2025 May;189:109834. (PMID: 40023073)
JMIR Med Inform. 2021 Mar 17;9(3):e23328. (PMID: 33609339)
Med Image Anal. 2024 Oct;97:103278. (PMID: 39059240)
Sci Rep. 2022 Sep 1;12(1):14851. (PMID: 36050406)
Nat Med. 2025 Feb;31(2):360-361. (PMID: 39825150)
IEEE Trans Image Process. 2004 Apr;13(4):600-12. (PMID: 15376593)
Eur Radiol Exp. 2020 Aug 20;4(1):50. (PMID: 32814998)
NPJ Digit Med. 2024 May 14;7(1):125. (PMID: 38744955)
NPJ Digit Med. 2023 Oct 9;6(1):186. (PMID: 37813960)
Lancet Oncol. 2024 Jul;25(7):879-887. (PMID: 38876123)
Nat Med. 2024 Apr;30(4):1166-1173. (PMID: 38600282)
Weitere Informationen
Background: Synthetic neuroimaging data has the potential to augment and improve the generalizability of deep learning models. However, memorization in generative models can lead to unintended leakage of sensitive patient information, limiting model utility and jeopardizing patient privacy.
Methods: We propose RELICT-NI (REpLIca deteCTion-NeuroImaging), a framework for detecting replicas in synthetic neuroimaging datasets. RELICT-NI evaluates image similarity using three complementary approaches: (1) image-level analysis, (2) feature-level analysis via a pretrained medical foundation model, and (3) segmentation-level analysis. RELICT-NI was validated on two clinically relevant neuroimaging use cases: non-contrast head CT with intracerebral hemorrhage (N = 774) and time-of-flight MR angiography of the Circle of Willis (N = 1,782). Expert visual scoring was used as the reference for identifying replicas. Balanced accuracy at the optimal threshold was reported to assess replica classification performance of each method.
Results: The reference visual rating identified 45 of 50 and 5 of 50 generated images as replicas for the NCCT and TOF-MRA use cases, respectively. For the NCCT use case, both image-level and feature-level analyses achieved perfect replica detection (balanced accuracy = 1) at optimal thresholds. A perfect classification of replicas for the TOF-MRA case was not possible at any threshold, with the segmentation-level analysis achieving the highest balanced accuracy (0.79).
Conclusions: Replica detection is a crucial but often neglected validation step in developing deep generative models in neuroimaging. The proposed RELICT-NI framework provides a standardized, easy-to-use tool for replica detection and aims to facilitate responsible and ethical synthesis of neuroimaging data.
Relevance Statement: Our developed replica detection framework provides an important step towards standardized and rigorous validation practices of generative models in neuroimaging. Our method promotes the secure sharing of neuroimaging data and facilitates the development of robust deep learning models.
(© 2025. The Author(s).)
Declarations. Ethics Approval and Consent to Participate: The data collection for this retrospective study was approved by the local Ethics Committees of following hospitals: Mie Chuo Medical Center institutional review board [permit number: MCERB-202321], Matsusaka Chuo General Hospital institutional review board [permit number: 325], Suzuka Kaisei Hospital institutional review board [permit number: 2020-05], and Mie University Hospital institutional review board [permit number: T2023-7]. Written informed consent was waived due to the retrospective nature of the analysis. Competing interests: The authors declare no competing interests.